Richard S. Levy, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 16,100 shares at $255.90 ($4.1M) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($4.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $255.90 | 4,387 | $1.1M | 27.1% |
| 2 | $255.90 | 4,387 | $1.1M | 27.1% |
| 3 | $256.88 | 3,900 | $1.0M | 24.2% |
| 4 | $257.93 | 1,600 | $413K | 10.0% |
| 5 | $259.07 | 100 | $26K | 0.6% |
| 6 | $265.28 | 713 |
| $189K |
| 4.6% |
| 7 | $265.28 | 713 | $189K | 4.6% |
| 8 | $267.07 | 300 | $80K | 1.9% |
| Total | $257.40 avg | 16,100 | $4.1M | 100% |
| Filing → |
| TARA | BUY | 2025-05-19 | $64K | — | Filing → |
| MDGL | SELL | 2024-11-08 | $1.8M | — | Filing → |
| MDGL | SELL | 2024-11-05 | $2.7M | — | Filing → |